Executive Summary
Today's 50 SEC filings reveal a market defined by divergent earnings trajectories, aggressive capital deployment, and a clear rotation toward electrification and infrastructure. Q3 2026 results show revenue growth across most sectors, but margin pressure is pervasive: Cactus, Veralto, and LyondellBasell all reported cost increases outpacing revenue, compressing margins.
In contrast, Regeneron and AstraZeneca delivered strong top-line beats, though both faced headwinds from legacy products and working capital. Capital allocation remains robust, with significant buybacks at GoDaddy ($1.3B), Regeneron ($2.3B), and ResMed ($936M), alongside strategic M&A in energy (Valero/LyondellBasell) and utilities (Alliant's 19% capex hike for data centers). Insider activity is notably absent from the enriched data, but 13F filings show institutional positioning heavily concentrated in mega-cap tech and ETFs, with some managers holding large cash-like positions. The most critical developments include Alliant's raised guidance and data center exposure, Valero's refinery acquisition, and the proposed Dominion-NextEra merger, which could reshape the utility landscape.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: 13F · 10-Q · 425 · S-3 · 8-K · 10-K · Schedule 13G · DEFA14A
Tracking the trend? Catch up on the prior US SEC Filings Daily Market Digest digest from October 22, 2026.
Investment Signals (12)
- Alliant Energy ↓ (BULLISH)▲
Q3 2026 ongoing EPS of $1.52 (+39% YoY), 2026 guidance narrowed to top half ($3.41-$3.46), 2027 guidance initiated at $3.63-$3.73 (+8% midpoint), and capex raised 19% to $15.9B to serve 3.4 GW of contracted data center demand
- Regeneron ↓ (BULLISH)▲
Q3 2026 revenue +36% YoY to $5.12B, non-GAAP EPS +70% to $20.07, Dupixent sales +35% to $6.5B, and full-year 2026 R&D guidance raised while SG&A guidance lowered, signaling operating leverage
- GoDaddy ↓ (BULLISH)▲
Q3 2026 revenue +6% YoY, operating income +22%, net income +24%, and $1.3B in buybacks reduced share count by 9.6%, boosting EPS to $2.08 from $1.51
- Valero Energy ↓ (BULLISH)▲
Agreed to acquire LyondellBasell's 700-acre Houston refinery site for $320.5M, adjacent to Valero's existing Houston refinery, with potential to resume refining operations by end-2026, enhancing Gulf Coast integration
- ResMed ↓ (BULLISH)▲
Q1 FY2027 revenue +5.9% YoY, net income +20% to $418.4M, EPS $2.92 vs $2.37, gross margin improved to 61.5%, and $936.4M in treasury stock purchases
- AstraZeneca ↓ (BULLISH)▲
9M 2026 revenue +8% to $46.9B, Core EPS +14% to $8.00, Q3 operating profit +22%, and core gross margin improved 1pp to 83%
- CubeSmart ↓ (BULLISH)▲
Q3 2026 FFO per share +1.5% to $0.66, same-store NOI +2.1%, and 2026 FFO guidance of $2.58-$2.60; modest but steady growth with a 4.1% dividend yield
- Dominion Energy ↓ (BULLISH)▲
Q3 2026 operating EPS $1.28 vs $1.06, revenue +24% to $5.6B, and expects top half of 2026 EPS guidance; proposed merger with NextEra could create a utility giant
- Cactus ↓ (BULLISH)▲
Q3 2026 revenue +63.2% YoY to $430.9M, net income +49.3% to $62.2M, EPS $0.87 vs $0.60, despite margin compression from acquisition costs
- Upbound Group ↓ (BULLISH)▲
Q3 2026 net earnings +159% to $34.3M, EPS $0.58 vs $0.22, operating profit +34.9%, and nine-month net earnings +71.3% on flat revenue, showing significant margin expansion
- Ryan Specialty ↓ (BULLISH)▲
Q3 2026 operating income +27.1% to $140.8M, net income +18% to $36.7M, and nine-month net income +74.4% to $96.6M, despite revenue growth of only 4.7%
- LyondellBasell ↓ (MIXED)▲
Q3 2026 net income swung to $758M from a $890M loss in Q3 2025, with EPS $2.32; however, results declined sharply from Q2 2026, highlighting volatility
Risk Flags (10)
- Veralto↓ [HIGH RISK]▼
Q3 2026 operating margin compressed to 19.7% from 23.2% YoY as SG&A jumped 20%, and nine-month operating profit slipped 1.0%; net earnings growth was aided by a lower tax rate (7.3% vs 21.9%) that may not repeat
- Cactus↓ [HIGH RISK]▼
Q3 2026 operating margin compressed to 21.8% from 23.2% YoY as total costs rose 66.2%, outpacing revenue growth of 63.2%; nine-month EPS fell to $0.89 from $1.83 due to an $81.5M NCI accretion charge
- Mastech Digital↓ [HIGH RISK]▼
Q3 2026 revenue -13.4% YoY to $42.0M, net income collapsed to $7K from $941K, operating income $13K vs $820K, and both segments declined; operating cash flow fell to $1.7M from $6.8M
- DXC Technology↓ [HIGH RISK]▼
Q2 FY27 revenue -4.0% YoY to $3.03B, net income -33% to $24M, and income before taxes -58.8%; first-half net income was boosted by a $251M other income benefit that may not recur
- Xerox↓ [HIGH RISK]▼
Exchange offer extends debt maturities to 2030 but raises coupon from 5.5% to 10.25%, signaling a materially higher cost of debt and potential liquidity concerns; largest holder Millennium affiliates offering 927K shares for resale
- OneMain Holdings↓ [HIGH RISK]▼
Q3 2026 net income -7% YoY to $185M, EPS $1.60 vs $1.67, provision for loan losses jumped to $615M from $488M, and net charge-offs rose to 6.89% from 6.67%
- Pharmaceutical Resource Technology↓ [HIGH RISK]▼
6-month 2026 revenue +3.7% but gross profit -19.1% as cost of revenue +34.2%, net loss of $322K vs profit of $880K, and gross margin compressed to 44.5% from 57.1%
- Naploy Corp↓ [HIGH RISK]▼
FY2026 revenue doubled to $18K but net loss widened to $31.7K, G&A exploded to $21K from $88, negative equity of $42.8K, and relies on related-party financing; filed NT 10-K for late annual report
- Banco Santander↓ [MEDIUM RISK]▼
Q3 2026 profit attributable to parent -2.1% YoY to €3.43B, profit for the period -6.5% to €3.64B, and 9M net cash from operations declined 11% with net debt widening to €25.8B
- LCI Industries↓ [MEDIUM RISK]▼
Board rejected unsolicited acquisition proposal from Monomoy Capital Partners, reaffirming Patrick Industries merger; potential for proxy fight or improved offer, but no financial terms disclosed
Opportunities (10)
- Alliant Energy↓ (OPPORTUNITY)◆
Data center demand (3.4 GW contracted) driving 19% capex increase to $15.9B, 2027 EPS guidance of $3.63-$3.73 (+8%), and top-half 2026 guidance; utility with visible growth from AI infrastructure
- Regeneron↓ (OPPORTUNITY)◆
Dupixent momentum (+35% to $6.5B) and EYLEA HD growth (+62% to $699M) offsetting legacy EYLEA decline; non-GAAP EPS +70%, R&D guidance raised, and $2.3B buyback with $2.2B remaining
- Valero Energy↓ (OPPORTUNITY)◆
$320.5M acquisition of adjacent Houston refinery site could restart refining operations by end-2026, enhancing integration and margins; deal expected to close by year-end
- Dominion Energy↓ (OPPORTUNITY)◆
Proposed merger with NextEra Energy could create a utility behemoth; Q3 operating EPS beat, 2026 guidance top half, and long-term growth reaffirmed
- ResMed↓ (OPPORTUNITY)◆
Sleep and Breathing Health revenue +7.7%, gross margin expansion, and $936M buyback; divestment gain of $61.8M boosted net income, but core operating income grew only 1.4%
- AstraZeneca↓ (OPPORTUNITY)◆
Core EPS +14%, Q3 operating profit +22%, and core gross margin improvement; pipeline and oncology strength could drive further upside
- CubeSmart↓ (OPPORTUNITY)◆
Stable FFO growth, 4.1% dividend yield, and 2026 FFO guidance midpoint of $2.59; self-storage sector resilient with same-store NOI +2.1%
- Upbound Group↓ (OPPORTUNITY)◆
Net earnings +159% and EPS $0.58 vs $0.22; subscriptions and fees +36.6% to $78.8M, and other gains/charges declining; potential for continued margin expansion
- Ryan Specialty↓ (OPPORTUNITY)◆
Nine-month net income +74.4% to $96.6M, operating income +27.1% in Q3, and $450M buyback; specialty insurance broker with strong organic growth
- Cactus↓ (OPPORTUNITY)◆
Revenue +63.2% and EPS $0.87 vs $0.60 despite margin pressure; acquisition deployment of $301M could drive future growth; oilfield services demand remains strong
Sector Themes (6)
- Margin Compression in Industrials/Tech (BEARISH FOR MARGINS)◆
5 of 10 companies with period comparisons reported margin compression (Cactus, Veralto, DXC, LyondellBasell, Mastech), averaging -200 bps YoY, driven by rising SG&A, acquisition costs, and input inflation; companies with pricing power (Regeneron, AstraZeneca) are exceptions
- Aggressive Capital Returns (BULLISH FOR SHAREHOLDERS)◆
Buybacks totaled over $5B across GoDaddy ($1.3B), Regeneron ($2.3B), ResMed ($936M), Ryan Specialty ($450M), and Veralto ($523M), often funded by debt (Veralto issued $719M) or cash reserves; this supports EPS but may limit flexibility
- Energy Transition and Infrastructure◆
Alliant raised capex 19% for data centers, Valero acquired refinery assets, and Dominion-NextEra merger talks highlight utility consolidation; power demand from AI is a secular tailwind [BULLISH FOR UTILITIES/ENERGY INFRASTRUCTURE]
- Healthcare Innovation vs. Legacy Pressure (BULLISH FOR INNOVATIVE BIOPHARMA)◆
Regeneron and AstraZeneca delivered strong growth from new drugs (Dupixent, EYLEA HD, oncology), while legacy products (EYLEA, Pulmatrix's pipeline) face declines; companies with innovative pipelines outperform
- Institutional Positioning in ETFs and Mega-Cap Tech (NEUTRAL)◆
13F filings show heavy concentration in ETFs (e.g., Southern Financial 69% ETF, Opus Capital 17% in Vanguard S&P 500) and mega-cap tech (NVIDIA, Apple, Microsoft), indicating passive and risk-averse positioning; active managers like Lyell Wealth hold concentrated tech bets
- Credit Quality Deterioration in Consumer Finance (BEARISH FOR CONSUMER LENDERS)◆
OneMain reported rising charge-offs (6.89% vs 6.67%) and provisions ($615M vs $488M), while Upbound saw bad debt expense rise to $75.1M from $55.8M; consumer stress is emerging
Watch List (8)
-
2027 EPS guidance of $3.63-$3.73 and $15.9B capex plan; watch for data center contract announcements and regulatory approvals for rate base growth
-
Acquisition of LyondellBasell's Houston refinery site expected to close by end-2026; monitor HSR clearance and potential restart timeline for refining operations
-
Proposed merger with NextEra Energy; watch for regulatory filings and shareholder approvals, as well as Q4 2026 EPS guidance reaffirmation
-
Full-year 2026 guidance raised for R&D and gross margin; watch for Dupixent sales trends and EYLEA HD uptake in Q4 2026 earnings
- 👁
Exchange offer for 10.25% senior secured notes due 2030 expected to execute November 13, 2026; monitor take-up rate and impact on capital structure
-
Board rejected Monomoy's unsolicited proposal; watch for potential revised offer or proxy contest ahead of Patrick Industries merger vote
-
Merger approved, expected to close Q4 2026 under ticker MTXL; interim aged-rat data for PTC-2105 showed mixed results, watch for further preclinical data
-
Special shareholder meeting adjourned to December 4, 2026 to vote on industry concentration policy; >98% of votes cast so far in favor, but quorum may be an issue
Filing Analyses
(50)
30-10-2026
Southern Financial Group, LLC filed its Q3 2026 13F-HR disclosing 89 holdings with an aggregate reported value of approximately $366.3M as of September 30, 2026. The portfolio is heavily concentrated in large ETF positions — JPMorgan Income ETF ($70.5M), Janus Henderson Income ETF ($57.6M), First Trust SMID Rising ETF ($50.5M), Janus Henderson Small Cap ETF ($40.9M), and Fidelity Hedged Equity ETF ($33.1M) — while individual equity stakes are comparatively small, led by Southern Co ($29.9M) and Apple ($2.8M). Notably, the book is dominated by fixed-income/income and factor ETFs rather than concentrated single-name equity bets, and the filing is a routine quarterly holdings disclosure with no period-over-period comparison data provided.
- · All 89 positions are held solely (SOLE voting authority) with zero shared or no-vote shares reported.
- · Portfolio is ETF-heavy: the top five ETF positions alone total roughly $252.5M, about 69% of the $366.3M book.
- · Largest single equity is Southern Co at $29.9M (360,304 shares), far below the top ETF positions.
- · Notable small/emerging positions include SpaceX Class A ($339.2K), Circle Internet Group ($592.3K), and Westwater Resources ($71.4K, 137,254 shares).
- · Filer is an Alabama-based LLC (Birmingham, AL) with SEC file number 028-27023 and CRD 801-67489.
- · No period-over-period holdings changes are disclosed in this filing; only the 09-30-2026 snapshot is provided.
29-10-2026
RADCOM LTD filed a 6-K on October 29, 2026, disclosing an indemnification agreement framework for directors/officers and confirming 17,056,892 Ordinary Shares outstanding (excluding shares held by subsidiary RADCOM, Inc. and repurchased shares). The filing contains no financial results or period-over-period operating metrics, consisting instead of legal/administrative provisions covering expense repayment, tax-related claims, and dividend distribution approvals. No revenue, earnings, or guidance data was provided, making this a neutral governance disclosure.
- · Indemnitee expense repayment obligations are treated as a loan subject to the minimum interest rate under Section 3(9) of the Income Tax Ordinance [New Version], 5721-1961
- · Indemnification covers a broad range of local and foreign taxes including income, sales, use, transfer, excise, value added, registration, severance, stamp, occupation, customs, duties, real property, personal property, capital stock, social security, unemployment, disability, payroll and withholding taxes, plus interest and penalties
- · All actions, consents and approvals relating to dividend distributions (cash or otherwise) under the Companies Law are addressed in the agreement
30-10-2026
Naploy Corp. filed an NT 10-K late filing notice on October 30, 2026, indicating it cannot file its Annual Report on Form 10-K for the fiscal year ended July 31, 2026 within the prescribed deadline because it needs additional time to prepare and review its financial statements to ensure adequate disclosure. The company checked the Rule 12b-25(b) box seeking relief and stated it does not anticipate any significant change in results of operations versus the prior fiscal year, though no quantitative figures were provided.
- · Fiscal year ended July 31, 2026; filing made October 30, 2026
- · Registrant incorporated in Wyoming, CIK 0001978111, SEC File Number 000-56729, classified under Services-Health Services [8000]
- · Principal executive office located at 95 Lias Estate Kafe District, Abuja, FCT 900108, Nigeria
- · Company affirmed all other periodic reports required under Section 13 or 15(d) during the preceding 12 months have been filed
- · Company answered 'No' to anticipating any significant change in results of operations from the corresponding prior-year period
- · Relief sought under Rule 12b-25(b); no accountant's statement exhibit (Rule 12b-25(c)) indicated as attached
- · Notification signed October 29, 2026 by President Frederick Sidney Reinhard Arnold; contact telephone 13072133163
30-10-2026
Garner Asset Management Corp filed its Q3 2026 13F-HR disclosing 162 holdings with an aggregate reported value of approximately $302.7 million as of September 30, 2026. The portfolio is heavily concentrated in mega-cap technology and index ETFs, with NVIDIA ($96.1M), Apple ($129.7M), Amazon ($64.9M), Microsoft ($46.7M) and Alphabet Class C ($60.6M) among the largest positions. The filing is a routine quarterly holdings disclosure with no period-over-period comparison data provided, so no growth or decline metrics can be derived.
- · Filer is Garner Asset Management Corp, a Texas-based investment adviser (SEC File No. 028-18125) located in Plano, TX
- · Report period is September 30, 2026; filing date October 30, 2026
- · Total reported portfolio value is $302,744,804 across 162 holdings
- · Largest single position is Apple Inc at $129,678,713 (3,770,700 shares)
- · NVIDIA position of $96,087,684 (4,448,500 shares) is the second-largest holding
- · Portfolio includes significant ETF exposure including State Street SPDR S&P 500 ETF Trust ($140,145,918, 183,100 units) and Invesco QQQ Trust ($204,372,312, 2,869,600 units)
- · Notable small/illiquid positions include Berkshire Hathaway Class A (100 shares, $821,931) and Seaboard Corp (19,600 shares, $75,655,019)
- · Significant BDC and closed-end fund exposure: Kayne Anderson Energy Infrastructure (28,875,800 shares), VanEck BDC Income ETF (32,275,300 shares), Virtus InfraCap (72,624,900 shares)
- · No period-over-period comparison data is disclosed in a 13F-HR filing; changes versus prior quarter cannot be determined from this document alone
30-10-2026
Vale reported Q3 2026 net operating revenue of $10,599M, up 1.7% YoY from $10,420M, but net income attributable to shareholders fell 53% to $1,255M from $2,685M as cost of goods sold jumped 19.7% to $7,940M, crushing gross profit 29.8% to $2,659M. Adjusted EBITDA declined 23.8% to $3,327M, with Iron Ore Solutions EBITDA down 33.7% to $2,633M while Vale Base Metals EBITDA rose 60.8% to $1,105M on copper strength. Nine-month revenue grew 11.0% to $30,355M, however nine-month net income fell 27.0% to $4,523M and EPS dropped to $1.06 from $1.45.
- · Q3 2026 Iron ore revenue fell to $2,078M from $3,418M YoY, while Copper revenue rose to $1,021M from $614M
- · China revenue declined to $4,980M in Q3 2026 from $5,695M in Q3 2025
- · Q3 2026 other operating expenses, net rose to $390M from $268M YoY
- · Q3 2026 equity results in associates swung to a loss of $197M from a gain of $160M
- · Q3 2026 income taxes were a $259M charge versus an $83M benefit in Q3 2025
- · Cash and cash equivalents fell to $4,841M at September 30, 2026 from $7,372M at December 31, 2025
- · 9M 2026 dividends and interest on capital paid to shareholders rose to $4,421M from $3,464M
- · 9M 2026 Samarco dam failure payments fell to $1,080M from $2,122M
- · 9M 2026 income tax payments fell to $832M from $1,622M
- · Total equity rose to $38,577M at September 30, 2026 from $34,350M at December 31, 2025
30-10-2026
Cactus, Inc. reported Q3 2026 total revenues of $430.9M, up 63.2% YoY from $264.0M, driven by product revenue (+55.9% to $322.3M) and field service/other revenue (+116.1% to $85.9M), while rental revenue grew 30.2% to $22.6M. Net income attributable to Cactus rose 49.3% YoY to $62.2M and diluted EPS improved to $0.87 from $0.60. However, nine-month EPS fell to $0.89 diluted from $1.83 due to an $81.5M accretion of redeemable non-controlling interest, and interest income declined sharply to $0.8M from $3.0M in the quarter; the company also deployed $301.0M net cash on a business acquisition, driving a $140.4M net decrease in cash for the nine months.
- · Total costs and expenses rose 66.2% YoY to $336.8M in Q3 2026, outpacing the 63.2% revenue growth and compressing operating margin to 21.8% from 23.2%
- · Selling, general and administrative expenses jumped 75.0% YoY to $62.8M in Q3 2026
- · Nine-month net income attributable to Cactus including NCI accretion fell to $62.6M from $126.2M due to the $81.5M accretion charge
- · Depreciation and amortization more than doubled to $100.2M for nine months 2026 from $47.8M
- · Accounts receivable used $84.1M of cash in nine months 2026 vs $9.5M in 2025, reflecting revenue growth and acquisition
- · Acquisition consideration of $362.0M included $344.5M initial cash, $45.5M minimum cash at closing, and $6.3M deferred payment
- · Acquired identifiable intangibles: customer relationships $169.7M (11-year life), developed technology $40.4M (10-year life), backlog $18.8M (1-year life)
- · Weighted average diluted Class A shares rose to 81.1M in Q3 2026 from 69.2M, reflecting CC Unit conversions
- · Dividends paid to Class A shareholders rose to $30.5M for nine months 2026 from $27.8M
- · Share repurchases totaled $8.1M for nine months 2026 vs $5.9M in 2025
30-10-2026
Veralto reported Q3 2026 sales of $1,509M, up 7.5% YoY from $1,404M, but operating profit fell 8.6% to $298M as SG&A jumped 20% to $541M, compressing operating margin to 19.7% from 23.2%. Net earnings rose 5.9% to $253M (diluted EPS $1.03 vs $0.95) on a sharply lower tax rate (7.3% vs 21.9%), while nine-month sales grew 7.3% to $4,405M but operating profit slipped 1.0% to $951M. The company deployed $683M on acquisitions (including In-Situ for $426M net) and repurchased $523M of stock, funded partly by $719M of new borrowings, lifting long-term debt to $2,671M from $1,973M and cutting cash to $1,785M from $2,031M.
- · Gross profit rose 7.6% to $908M in Q3 2026 from $844M, with gross margin roughly flat at 60.2% vs 60.1%.
- · R&D expenses increased 3.0% to $69M in Q3 2026 from $67M.
- · Nine-month comprehensive income fell 18.2% to $675M from $825M, driven by foreign currency translation losses of $94M vs a $200M gain prior year.
- · Accumulated other comprehensive loss widened to $986M from $913M at year-end 2025.
- · Share repurchases totaled $528M through Q3 2026 (3.2M + 1.5M + 1.0M shares), with treasury stock of $528M vs zero at year-end 2025.
- · Dividends declared of $31M in Q3 2026 and $96M paid over nine months, up from $82M prior year.
- · Short-term borrowings and current portion of long-term debt fell to $249M from $700M at December 31, 2025.
- · Goodwill rose to $3,200M from $2,838M and intangibles to $820M from $524M, reflecting acquisitions.
- · In-Situ acquisition added $433M of net assets acquired, including $223M goodwill and $198M developed technology.
- · Cash and equivalents declined $246M over nine months to $1,785M, versus a $674M increase in the prior-year period.
- · Diluted share count fell to 245.3M from 250.6M in Q3, reflecting buybacks.
30-10-2026
Xerox filed an S-3 resale registration covering common stock issued to holders of its 5.500% Senior Notes due 2028 who exchange into newly issued 10.250% Senior Secured First Lien Notes due 2030, accrued interest cash, and common stock under an Exchange Support Agreement signed October 29, 2026, with Exchange Agreements expected November 13, 2026. Xerox will receive no proceeds from resales. The deal extends maturities to 2030 but raises the coupon from 5.500% to 10.250%, signaling a materially higher cost of debt, while the largest selling holder (Millennium affiliates) holds 3,518,225 shares (2.56%) and offers 926,962 for resale, retaining 2,591,263 shares (1.89%).
- · Exchange Agreements expected to be executed November 13, 2026; S-3 filed October 29, 2026
- · Exchanging holders receive new notes, cash for accrued/unpaid interest, and common stock; holders barred from holding equity receive additional principal of new notes instead
- · Xerox organized as a New York corporation in 2019; principal offices at 401 Merritt 7, Norwalk, Connecticut 06851-1059
- · Xerox describes itself as a workplace technology company investing in AI, IoT, IDP, RPA and IT infrastructure
- · Millennium affiliate holdings include warrants: Integrated Core Strategies (US) LLC 210,338 warrants; ICS Opportunities, Ltd. 1,928,534 warrants; Integrated Assets, Ltd. 34,524 warrants
- · All selling stockholders other than Millennium affiliates hold less than 1% each
30-10-2026
Challenger Wealth Management filed its Q3 2026 13F-HR disclosing 63 holdings valued at $136,995,716 as of September 30, 2026. The portfolio is heavily concentrated in Capital Group ETFs, with Capital Group Dividend Value ($23.0M), Capital Group Growth ETF ($20.6M), and Capital Group Core Equity ETF ($11.3M) as the three largest positions, together representing roughly 40% of reported value. Core mega-cap equities (Apple $6.4M, Alphabet Class A $3.1M, Amazon $4.1M, Nvidia $4.4M, ExxonMobil $4.6M) round out the book, while several positions are small (e.g., Aurora Innovation $88,579, UnitedHealth $207,461).
- · All 63 positions are held in sole voting authority with no shared or discretionary split reported (0 shared/0 other).
- · Three Capital Group ETFs plus Core Balanced total approximately $59.8M, about 44% of the $136,995,716 portfolio.
- · Smallest positions include Aurora Innovation ($88,579), UnitedHealth ($207,461), Entergy ($231,531), and McDonald's ($241,491).
- · Filer is Challenger Wealth Management, SEC file number 028-25401, CRD 801-130287, based in Aliso Viejo, CA.
- · Report period is 09-30-2026; filing signed by Nancy H Challenger on 10-29-2026.
- · Notable positions include SpaceX Class A ($547,320) and ASML ($1,150,410).
30-10-2026
ResMed reported Q1 FY2027 (three months ended September 30, 2026) net revenue of $1,414.8M, up 5.9% YoY from $1,335.6M, driven by Sleep and Breathing Health products (+7.7% to $1,259.8M) while Residential Care Software revenue declined 6.7% to $155.0M. Net income jumped 20.0% YoY to $418.4M (diluted EPS $2.92 vs $2.37), boosted by a $61.8M gain on divestment of subsidiaries, while operating income grew only 1.4% to $453.0M as R&D (+15.0%) and SG&A (+11.7%) rose faster than revenue. Cash and equivalents fell to $1,010.7M from $1,469.2M at June 30, 2026, reflecting $936.4M of treasury stock purchases and a $250.0M debt repayment, and total assets declined to $8,211.8M from $8,966.0M.
- · Gross margin improved to 61.5% from 61.2% YoY
- · R&D expense rose to $102.9M from $89.5M; SG&A rose to $314.7M from $281.6M
- · Total other income, net was $86.2M vs $0.3M prior year, largely on the $61.8M divestment gain
- · Treasury stock purchases of $936.4M vs $150.0M prior year; treasury shares rose to 50.4M from 46.8M
- · Short-term debt fell to $160.0M and long-term debt to $249.6M after $250.0M repayment
- · Assets held for sale of $457.4M at June 30, 2026 reduced to zero after divestment
- · Dividend raised to $0.66 per share from $0.60
- · Unrealized hedging losses of $81.0M drove accumulated other comprehensive loss to $131.7M
- · Prior-year figures were reclassified to move amortization of acquired intangibles into cost of sales and SG&A
30-10-2026
Alliant Energy reported Q3 2026 GAAP EPS of $1.52, up 39% from $1.09 in Q3 2025, and nine-month 2026 EPS of $3.04 (+17% YoY) with ongoing EPS of $2.99 (+14%). The company narrowed 2026 ongoing EPS guidance to $3.41-$3.46 (top half of prior range) and issued 2027 guidance of $3.63-$3.73 (+8% at midpoint), while raising its four-year capex forecast 19% to $15.9 billion to serve 3.4 GW of contracted data center demand. However, results were partly offset by higher O&M, financing and depreciation expenses, and the Q3 beat was aided by income tax timing variances that will reverse by year-end.
- · Q3 2026 ongoing EPS of $1.52 vs $1.12 in Q3 2025
- · Q3 2026 results included a $0.05 per-share benefit from deferred tax asset remeasurement; Q3 2025 included a $0.03 per-share charge
- · Rate base growth contributed $0.05 per share at IPL and $0.12 per share at WPL
- · Temperature-driven retail electric and gas sales added an estimated $0.05 per share in Q3 2026 vs $0.03 in Q3 2025
- · Higher O&M (labor), electric distribution/generation maintenance, financing and depreciation expenses partially offset gains
- · Income tax timing variances will reverse by end of year
- · 2027 guidance midpoint of $3.68 represents 8% growth over 2026 original guidance midpoint
- · 2027 capex breakdown: Renewables/energy storage $1,250M, Thermal/LNG $2,090M, Electric systems $540M, Gas systems $150M, Other $275M
- · 2028 capex peaks at $4,735M, with renewables/energy storage at $1,890M
- · Conference call scheduled October 30, 2026 at 9 a.m. Central Time
30-10-2026
Upbound Group reported Q3 2026 total revenues of $1,146.2M, down 1.6% YoY from $1,164.7M, as rentals and fees fell 2.2% and merchandise sales dropped 9.0%, partly offset by a 36.6% jump in subscriptions and fees to $78.8M. Profitability improved sharply, however, with operating profit up 34.9% to $71.2M and net earnings up 159% to $34.3M ($0.58 diluted EPS vs $0.22), helped by lower cost of revenues and a $20.9M decline in other gains and charges. Nine-month net earnings rose 71.3% to $91.6M on roughly flat revenue (+0.9%), while non-labor operating expenses climbed 10.6% and bad debt expense rose to $75.1M from $55.8M.
- · Other gains and charges fell to $32.5M in Q3 2026 from $53.4M in Q3 2025, and to $125.3M from $162.1M for nine months, aiding profit growth.
- · General and administrative expenses rose 21.3% YoY in Q3 to $60.9M from $50.2M.
- · Rental merchandise on rent declined to $1,043.8M at September 30, 2026 from $1,202.3M at December 31, 2025.
- · Total assets fell to $3,052.1M from $3,276.1M at year-end 2025; total stockholders' equity rose to $750.1M from $695.7M.
- · Nine-month 2026 investing outflow was $115.6M versus $374.9M in 2025, which included $278.0M of acquisition spending.
- · Financing activities used $337.0M in nine months 2026 versus $156.0M provided in 2025, reflecting $485.6M of debt repayments against $260.0M of proceeds.
- · Quarterly dividends of roughly $22.8M were declared in each quarter of 2026.
- · Deferred tax liability increased to $137.5M from $108.6M at December 31, 2025.
- · Pro forma net earnings for Q3 2025 including the January 2025 acquisition were $14.6M versus reported $13.2M.
30-10-2026
GoDaddy reported Q3 2026 total revenue of $1,341.8M, up 6.0% YoY from $1,265.3M, with Applications and Commerce growing 9.0% to $524.3M while Core Platform grew a slower 4.2% to $817.5M. Operating income jumped 22.2% to $362.5M and net income rose 24.4% to $261.8M, but the effective tax rate climbed sharply (provision up 25.3% to $70.8M) and total stockholders' equity swung to a deficit of $(138.8)M from $215.1M at year-end 2025 amid $1,305.0M of buybacks. Diluted EPS improved to $2.08 from $1.51, though the diluted share count fell 9.6% to 125,696K, flattering per-share results.
- · Nine-month 2026 revenue rose 6.2% to $3,906.7M from $3,677.2M, with operating income up 25.3% to $1,015.5M.
- · Nine-month 2026 income tax provision more than doubled to $215.0M from $96.2M, pressuring net income growth.
- · Depreciation and amortization fell to $50.2M in nine-month 2026 from $89.8M a year earlier.
- · Marketing and advertising expense declined 4.4% to $273.0M for nine months 2026, while technology and development rose slightly to $635.2M.
- · Goodwill declined to $3,602.1M from $3,633.3M and deferred tax assets fell to $845.7M from $1,052.6M at year-end 2025.
- · Accumulated deficit widened to $(3,394.9)M from $(2,789.4)M at December 31, 2025.
- · Q3 2026 buybacks totaled $481.8M (5,026K shares); nine-month repurchases were $1,305.0M versus $1,383.0M in 2025.
- · Cash and cash equivalents rose to $1,119.8M from $1,080.9M at year-end 2025.
30-10-2026
Arlington Capital Management, Inc. filed its Q3 2026 13F-HR disclosing 113 holdings valued at $174,380,654 as of September 30, 2026. The portfolio is heavily concentrated in ETFs and semiconductors, led by NVIDIA ($15.99M), Invesco Semiconductor ETF ($11.68M), VanEck Oil Services ETF ($9.39M), and iShares MSCI South Korea ETF ($7.54M). The filing is a routine institutional holdings disclosure with no period-over-period comparison data provided, so no growth or decline metrics can be calculated.
- · All 113 positions are held in sole voting/discretionary authority with zero shared or no-vote shares reported.
- · Portfolio includes several country-specific ETFs (South Korea $7.54M, Turkey $4.31M, Finland $3.64M, Poland $0.30M, Greece $0.33M) indicating international exposure.
- · Notable small/emerging positions include Ryde Group ($11,818), Grayscale Bitcoin Trust ($0.30M), and IREN Limited ($0.24M).
- · Filer is an Illinois-based entity (Arlington Heights, IL) with SEC file number 028-16665.
- · Filing was signed by Shannon Hemphill, Compliance Consultant, on October 29, 2026.
- · No prior-period holdings data is included in this filing, so quarter-over-quarter position changes cannot be determined.
30-10-2026
Stiles Financial Services Inc filed its Q3 2026 13F-HR disclosing 178 holdings valued at $392,252,420 as of September 30, 2026. The portfolio is heavily concentrated in mega-cap technology, with NVIDIA ($36.6M) as the largest position, followed by Lam Research ($15.6M), Apple ($13.4M), AMD ($13.1M), and ASML ($11.4M). The book is broadly diversified across semiconductors, energy, healthcare, REITs, and ETFs, with all positions held solely in-house and no options or put/call exposure reported.
- · All 178 positions are held with sole voting authority; no shared or no-vote shares reported.
- · No put or call options positions disclosed in the information table.
- · Portfolio includes a small Bitcoin exposure via Fidelity Wise Origin Bitcoin Fund (4,034 shares, $293,030).
- · Notable ETF allocations include Invesco QQQ ($2.5M), BNY Mellon Core Bond ETF ($2.2M), and Allspring Broad Market Core Bond ETF ($1.3M).
- · Other sizable positions: Qualcomm ($5.1M), Fastenal ($5.3M), Steel Dynamics ($4.6M), Applied Materials ($4.5M), Broadcom ($4.3M), Texas Instruments ($4.8M), Target ($4.2M).
- · Filing signed by Jade Franke, Compliance Consultant, dated 10-29-2026; filer is a Minnesota-based firm (CRD/file 028-21679).
- · No prior-period holdings data included in this filing, so quarter-over-quarter position changes cannot be calculated.
30-10-2026
BancFirst Trust & Investment Management filed its Q3 2026 13F-HR disclosing 66 holdings valued at $190,181,784 as of September 30, 2026. The portfolio is heavily concentrated in BancFirst Corp (05945F103) at $96,964,598 across 911,749 shares, roughly 51% of total reported value, alongside large index-fund positions in Vanguard Total Bond Market ($11,139,882) and Vanguard S&P 500 ETF ($10,524,255). The filing is a routine quarterly holdings disclosure with no period-over-period comparison data provided, so no growth or decline metrics can be calculated.
- · BancFirst Corp common stock represents approximately 51% of total reported portfolio value, indicating extreme single-name concentration.
- · BancFirst Corp position includes 30,665 shares with shared voting authority and 881,084 shares with no voting authority.
- · ExxonMobil Holdings Corp is the second-largest corporate equity position at $11,852,139 (73,456 shares sole) plus $383,367 in OTR accounts.
- · Fixed-income and index ETF exposure is substantial: Vanguard Total Bond Market $11,139,882, Vanguard S&P 500 ETF $10,524,255, Vanguard Short-Term Bond $6,507,793, Vanguard Intermediate-Term Bond $2,987,476.
- · OGE Energy Corp is split unusually between sole accounts ($69,068, 1,522 shares) and OTR accounts ($1,566,199, 34,513 shares).
- · Stardust Power Inc is the smallest position at $2,397 (23,011 shares).
- · Filing signed by N. Quinton Tews, Trust Compliance Officer, dated 10-29-2026; SEC file number 028-22341.
30-10-2026
Banco Santander reported 9M 2026 total income of €46,713M, up 8.0% YoY from €43,248M, and profit attributable to the parent of €12,405M, up 20.0% YoY from €10,337M, lifting basic EPS to €0.83 from €0.66. However, Q3 2026 profit attributable to the parent slipped 2.1% YoY to €3,432M from €3,504M, as Q3 profit for the period fell 6.5% to €3,636M versus €3,890M a year earlier when discontinued operations contributed €426M. Total assets grew 12.6% to €2,102,334M, driven by financial assets at amortised cost (+17.6%) and a near-doubling of intangible assets/goodwill (+51.0%), while non-current assets held for sale collapsed to €2,831M from €75,011M.
- · Q3 2026 profit for the period of €3,636M included no contribution from discontinued operations, versus €426M in Q3 2025
- · 9M 2026 profit after tax from discontinued operations was €1,895M, up from €1,152M
- · Profit attributable to non-controlling interests fell to €645M in 9M 2026 from €1,016M
- · Administrative expenses rose 3.2% to €16,518M in 9M 2026, with staff costs up 4.5% to €10,516M
- · Provisions or reversal of provisions, net rose to €2,422M in 9M 2026 from €1,709M
- · Impairment on non-financial assets jumped to €527M in 9M 2026 from €188M, including €496M on intangibles
- · Other comprehensive income improved to €2,437M attributable to the parent in 9M 2026 from a €37,974M accumulated loss position at year-end 2025
- · Own shares rose to €1,533M at 30-09-2026 from €96M at 31-12-2025, reflecting €7,454M of buybacks
- · A business combination on 20 August 2026 had total assets of €70,994M, net acquired assets of €5,170M and consideration of €10,724M, generating €5,553M of goodwill
- · Operating cash flow was €12,925M in 9M 2026 versus negative €7,818M in 9M 2025
- · Loan commitments granted rose to €342,782M from €321,234M at 31-12-2025
30-10-2026
DXC Technology reported Q2 FY27 revenue of $3,034M, down 4.0% YoY from $3,161M, while net income attributable to common stockholders fell 33% to $24M ($0.15 diluted EPS) from $36M ($0.20). First-half net income more than doubled to $146M ($0.89 diluted) from $52M, helped by a $251M other income benefit and lower SG&A ($647M vs $760M), but revenue declined 4.5% to $6,033M and operating cash flow rose only 6.7% to $635M. The company returned $132M via buybacks and repaid $400M of long-term debt, reducing total debt to $3,059M from $3,552M, while cash fell to $1,599M from $1,737M at fiscal year-end.
- · Q2 FY27 income before income taxes fell 58.8% to $54M from $131M, with income tax expense of $41M vs $91M
- · Q2 FY27 net loss attributable to non-controlling interest was $11M vs income of $4M a year earlier
- · Six-month FY27 other income, net of $251M (vs $95M) materially boosted pre-tax income
- · Six-month FY27 depreciation and amortization declined to $553M from $599M; software purchased and developed fell to $48M from $113M
- · Six-month FY27 net cash used in financing activities was $618M vs $246M, driven by $400M debt repayment
- · Total debt fell to $3,059M (current $935M + long-term $2,124M) from $3,552M at March 31, 2026
- · Intangible assets, net declined to $1,370M from $1,612M; goodwill flat at $527M
- · Accumulated deficit improved to $(2,401)M from $(2,937)M
- · Six-month FY27 comprehensive income attributable to DXC was $224M vs $(67)M loss prior year, aided by $65M favorable FX translation
- · Share count reduced via 12,367 thousand shares repurchased for $522M in additional paid-in capital reduction during six-month FY27
30-10-2026
Factory Mutual Insurance Co filed its Q3 2026 13F-HR disclosing $11.21B in reportable holdings across 216 positions as of September 30, 2026. The portfolio is heavily concentrated in mega-cap technology and index ETFs, led by NVIDIA ($626.9M), Apple ($542.1M), Alphabet Class C ($500.6M), Microsoft ($473.5M), and Amazon ($350.2M), with large fixed-income and sector ETF allocations. However, several positions are comparatively small, including minor stakes in Adobe ($215,946), Salesforce ($631,318), and MongoDB ($697,220), reflecting a barbell structure rather than uniform conviction.
- · Filing signed by Sanjay Chawla, Chief Investment Officer, on October 29, 2026
- · Report period: September 30, 2026; filed October 30, 2026
- · All 216 positions reported as sole voting authority with zero shared or discretionary-none holdings
- · Significant fixed-income ETF allocation: Dimensional Core Fixed Income ($405.0M), iShares Core US Aggregate Bond ($383.4M), JPMorgan Core Plus Bond ($357.5M)
- · Large sector ETF positions include Energy ($273.7M), Technology ($183.4M), and Utilities ($124.8M)
- · Smallest disclosed positions include Adobe (900 shares, $215,946), Praxis Precision Medicines (1,019 shares, $296,763), and Glaukos (2,129 shares, $349,561)
30-10-2026
LyondellBasell reported Q3 2026 net income of $758 million ($2.32 diluted EPS), or $828 million ($2.54 per share) excluding $70 million of identified items, with EBITDA of $1.4 billion ($1.5 billion excluding items). Sales fell 7.4% sequentially to $8,499 million from $9,177 million in Q2 2026, though they rose 10.0% YoY versus $7,727 million, and net income swung to profit from a $890 million loss in Q3 2025. However, profitability declined sharply versus the prior quarter, with net income down 45.8% from $559 million and EBITDA down 28.9% from $1,420 million, as O&P Americas margins fell on lower polymer and olefin prices and O&P Europe/Asia/International was pressured by lower polymer prices and reduced volumes following the May 2026 European asset sale, partially offset by materially higher Intermediates & Derivatives profitability driven by oxyfuels.
- · Identified items of $70 million net of tax included closure costs for a European propylene oxide (PO) joint venture, impacting EPS by $0.22 per share
- · O&P Americas profitability fell sequentially on lower polymer and olefin prices
- · O&P Europe, Asia and International polymer prices fell and volumes were lower sequentially reflecting the May 2026 sale of certain European assets
- · Intermediates & Derivatives delivered materially higher quarterly profitability largely driven by oxyfuels; Bayport PO/TBA operated at full rates after a June restart
- · Q3 2026 cash from operating activities of $1.7 billion included a release of working capital
- · Q4 2026 expected operating rates: 85% North American O&P, 60% European O&P, 75% Intermediates & Derivatives; planned maintenance at a North American polypropylene asset
- · Conference call October 30 at 11 a.m. EDT; replay available until November 30, 2026 (access ID 13746219)
- · Nine months 2026 net income of $1,442 million versus a $598 million loss in nine months 2025
30-10-2026
Valero Energy agreed on October 29, 2026 to acquire all equity interests of LYB Houston Hub Holdings LLC from a LyondellBasell subsidiary for $320.5 million, subject to closing adjustments. The target indirectly owns an approximately 700-acre former petroleum refinery facility adjacent to Valero's Houston refinery on the Houston Ship Channel. Closing is subject to customary conditions including HSR antitrust clearance and is expected by the end of 2026; the deal contemplates potential resumption of refining operations, though no financial return figures were disclosed.
- · Definitive agreement signed October 29, 2026; press release issued October 30, 2026
- · Acquirer is Valero Refining-Texas, L.P., a wholly owned subsidiary of Valero
- · Seller is a subsidiary of LyondellBasell Industries N.V.
- · Closing conditions include expiration or termination of the Hart-Scott-Rodino waiting period
- · Transaction expected to close by the end of 2026
- · Transaction presentation posted on investorvalero.com (Exhibit 99.02); press release is Exhibit 99.01
- · Forward-looking statements reference expected financial return of the acquisition and potential resumption of refining operations, but no return figures were disclosed
30-10-2026
Marti Technologies announced a partnership with China-based autonomous driving provider CalmCar to bring autonomous driving technology to its mobility platform in Türkiye, with the first CalmCar-equipped vehicle having arrived in Türkiye and closed-area testing in Istanbul expected to begin subject to obtaining required test permits. Marti cites its ride-hailing footprint across 40 cities (~90% of Türkiye's GDP) and approximately 8.3 million all-time unique platform consumers as deployment advantages. However, the release contains no financial terms, no revenue or profitability metrics, and no timeline for commercial launch, with testing explicitly contingent on regulatory permits and the partnership framed as exploratory.
- · CalmCar was founded in 2016 and is headquartered in Suzhou, China
- · CalmCar's Level 4 technology powers robobus services in regular operation in Chongqing and Chengdu
- · Marti was founded in 2018 and trades on NYSE American under ticker MRT
- · Marti also offers delivery services and rental e-mopeds, e-bikes and e-scooters alongside ride-hailing
- · No financial terms, investment amounts, or commercial launch timeline were disclosed for the partnership
- · Testing commencement is conditional on obtaining required test permits from Turkish authorities
- · Marti files annual reports on Form 20-F as a foreign private issuer
30-10-2026
OneMain reported Q3 2026 net income of $185 million and diluted EPS of $1.60, down from $199 million and $1.67 in the prior year quarter, while C&I adjusted EPS fell to $1.51 from $1.90. Managed receivables grew 9% YoY to $28.1 billion and originations rose 17% to $4.5 billion, but the provision for finance receivable losses jumped to $615 million from $488 million and net charge-offs rose to 6.89% from 6.67%, pressuring profitability. The company declared a $1.05 quarterly dividend and repurchased 538 thousand shares for $34 million.
- · 30+ delinquency ratio improved to 5.34% at Sep 30, 2026 from 5.55% a year earlier, and 90+ delinquency improved to 2.26% from 2.35%.
- · Net charge-offs rose to 6.89% in Q3 2026 from 6.67% in Q3 2025, though down from 7.77% in Q2 2026.
- · C&I adjusted pretax income fell 23.4% YoY to $232 million from $303 million.
- · Principal debt outstanding was $24.4 billion, 52% secured; liquidity includes $936 million cash, $1.0 billion undrawn revolver, $6.5 billion undrawn conduit/VFN capacity, and $12.3 billion unencumbered receivables.
- · Book value per basic share rose to $29.59 from $28.53 a year earlier; return on assets was 2.6% vs 3.0%.
- · Dividend of $1.05 per share payable November 13, 2026 to holders of record November 9, 2026.
- · Conference call scheduled 9:00 am Eastern Time on October 30, 2026.
30-10-2026
Flowco Holdings Inc. (NYSE: FLOC) filed an 8-K on October 30, 2026 announcing a quarterly cash dividend of $0.09 per share of Class A common stock, payable November 24, 2026 to holders of record as of November 13, 2026. Its operating subsidiary Flowco MergeCo LLC will make a corresponding $0.09 per unit distribution to common unitholders. The filing contains no financial results or period-over-period performance data, so no growth or decline metrics can be assessed.
- · Record date for the dividend is close of business on November 13, 2026
- · Dividend payment date is November 24, 2026
- · Class A Common Stock has a par value of $0.0001 per share and trades under ticker FLOC on both NYSE and NYSE Texas
- · Company is an emerging growth company under SEC rules
- · Press release furnished as Exhibit 99.1; information is not deemed 'filed' under Section 18 of the Exchange Act
- · Company incorporated in Delaware, IRS Employer Identification No. 99-4382473, Commission File Number 001-42477
- · Principal executive offices located at 1300 Post Oak Blvd., Suite 450, Houston, Texas 77056
30-10-2026
Munich Reinsurance Co Stock Corp in Munich filed its quarterly 13F-HR for the period ended September 30, 2026, disclosing 146 holdings valued at $4,531,422,358 held via MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH. The portfolio is heavily concentrated in mega-cap technology, with Microsoft ($329.8M), NVIDIA ($309.2M), Broadcom ($138.7M), Advanced Micro Devices ($121.8M), and Deutsche Bank ($122.8M) as the largest positions. However, the book is broadly diversified across financials, healthcare, industrials, and consumer names, with many positions (e.g., Target, Lowe's, Colgate-Palmolive, IBM, GE Vernova) held in very small share counts, indicating a passive/index-tracking or legacy residual structure rather than high-conviction active bets.
- · All 146 positions are held SOLE (sole voting/dispositive authority) with no shared or other-manager discretion reported.
- · Portfolio includes a $9.5M position in Space Exploration Technologies (SpaceX) Class A common stock (63,178 shares).
- · Several positions are tiny residual stakes: Target (766 shares, $120,025), Lowe's (726 shares, $133,795), IBM (537 shares, $118,102), GE Vernova (129 shares, $122,613), Caterpillar (312 shares, $252,966).
- · Dual-class exposure to Alphabet: Class C $114.1M (334,849 shares) and Class A $105.6M (306,999 shares).
- · Canadian holdings include Bank of Nova Scotia, Celestica, Enbridge, Gildan Activewear, Kinross Gold, Nutrien, Shopify, Sun Life Financial, and Toronto-Dominion Bank.
- · Filing signed by Bjorn Reichwald, Head of Department, dated October 21, 2026; SEC file number 028-25844; film number 261504365.
- · No period-over-period comparison data is included in this 13F-HR filing (holdings-only report).
30-10-2026
Regeneron reported Q3 2026 total revenues of $5,115.8M, up 36.3% YoY from $3,754.3M, driven by collaboration revenue surging 52.4% to $3,000.5M (including Sanofi profit share of $2,574.9M, up 76.9%) and net product sales rising 13.7% to $1,805.3M. Net income jumped 33.5% to $1,948.7M and diluted EPS rose 35.5% to $18.45, however other income, net plunged 67.4% to $246.5M from $755.8M and gross margin pressure showed in cost of goods sold rising 14.5% versus 13.7% product sales growth. Nine-month operating cash flow slipped 3.5% to $3,675.3M despite net income growth, and the company repurchased $2,363.4M of stock while cash and equivalents rose to $3,659.1M.
- · Accounts receivable rose to $7,578.6M from $5,741.1M at year-end 2025, driving a $1,850.5M cash use in nine-month operating activities versus a $549.3M source in 2025.
- · Inventories declined to $2,894.6M from $3,200.8M, a $110.7M cash source versus a $277.4M use in the prior year.
- · Nine-month 2026 net income of $3,972.8M grew only 8.5% versus 24.4% revenue growth, reflecting a $693.0M other income figure versus $1,520.6M in 2025.
- · Acquired in-process R&D expense rose to $250.4M for nine months 2026 from $105.4M, while Q3 2026 IPR&D fell to $21.5M from $83.1M.
- · Capital expenditures increased to $771.0M from $649.7M in the prior-year nine months.
- · Dividends declared of $98.3M in Q3 2026 and $290.3M paid over nine months; quarterly dividends were roughly $0.97 per share.
- · Accumulated other comprehensive income swung to a $197.5M loss from $77.5M income at year-end 2025, driven by $274.6M unrealized losses on debt securities.
- · A new $720.0M finance lease liability was reclassified from long-term to current at September 30, 2026.
- · Total stockholders' equity rose to $33,498.5M from $31,256.9M at December 31, 2025.
30-10-2026
Regeneron reported Q3 2026 total revenues of $5,116 million, up 36% YoY from $3,754 million, with GAAP diluted EPS up 35% to $18.45 and non-GAAP diluted EPS up 70% to $20.07. Growth was driven by Dupixent global net sales (+35% to $6.5 billion), EYLEA HD U.S. (+62% to $699 million), Libtayo global (+51% to $550 million), and a 68% jump in Sanofi collaboration revenue to $2,724 million. However, legacy EYLEA U.S. net sales fell 41% to $400 million (total EYLEA HD + EYLEA U.S. down 1% to $1,099 million) and Bayer collaboration revenue declined 23% to $267 million, leaving overall net product sales growth at a more modest 14% to $1,805 million.
- · Full-year 2026 guidance raised for R&D (GAAP $6.600–$6.735B from $6.500–$6.635B) and gross margin (GAAP ~80% from 78–79%), while SG&A guidance was lowered (GAAP $2.730–$2.860B from $2.830–$2.960B)
- · GAAP effective tax rate fell to 14.7% from 17.2%, with Q3 2025 including a $45 million OBBBA-related deferred tax charge; non-GAAP ETR rose to 15.0% from 13.1%
- · Company repurchased $2.3 billion of common stock in the nine months ended September 30, 2026, with $2.2 billion remaining under authorization
- · Declared quarterly cash dividend of $0.94 per share, payable December 3, 2026 to holders of record November 20, 2026
- · Sanofi Development Balance was fully repaid as of end of Q2 2026, no longer reducing Sanofi collaboration revenue beginning Q3 2026
- · FDA approved Pasatru (garetosmab) in August 2026 for FOP; EU application under review
- · FDA decision expected next month for cemdisiran in generalized myasthenia gravis; Ordspono BLA resubmission target action date February 2027; Libtayo six-week dosing sBLA target action date March 2027
- · CIDEB RNAi single dose reduced liver fat ~70% on average at 12 weeks, sustained through 24 weeks; Phase 3 in MASH/MASLD planned Q4 2026
- · GAAP gross margin on net product sales flat at 82% YoY; non-GAAP flat at 86%
30-10-2026
AstraZeneca reported 9M 2026 total revenue of $46,881M, up 8% actual (7% CER) from $43,236M, with Q3 revenue up 7% to $16,209M. Reported operating profit rose 10% to $11,797M for 9M and 22% to $4,387M in Q3, while Core EPS grew 14% to $8.00 (Q3 Core EPS $2.79, +17%). However, net cash from operating activities declined 11% to $10,890M from $12,233M on a $1,794M working capital outflow, and net debt widened to $25,833M from $23,374M at year-end 2025, with R&D expense up 10% and SG&A up 9%.
- · Tax rate improved to 18% for 9M 2026 from 19% in 9M 2025; Q3 tax rate 21% vs 22%
- · Core gross margin 83% with +1pp CER improvement; Q3 core gross margin 82%
- · Core R&D as % of revenue fell to 23% (9M) from 24% reported basis; Q3 core R&D 22%
- · Core SG&A as % of revenue 25% vs 33% reported (9M); Q3 core 24% vs 32% reported
- · Movement in working capital swung to a $1,730M outflow from a $64M inflow year-on-year
- · Taxation paid rose to $2,634M from $2,193M; interest paid $1,147M vs $1,069M
- · Net increase in cash and cash equivalents fell to $2,235M from $2,609M
- · Commercial paper of $1,619M at 30 Sep 2026 vs nil at 31 Dec 2025; lease liabilities rose to $2,777M from $1,803M
- · Collaboration revenue more than tripled in Q3 to $36M from $11M
- · Other operating income & expense more than doubled to $618M (9M) and more than tripled to $277M in Q3
30-10-2026
LCI Industries disclosed that its Board unanimously rejected an unsolicited, non-binding acquisition proposal from Monomoy Capital Partners, determining it is not a superior proposal and not reasonably likely to lead to one. This reaffirms the company's commitment to its previously announced merger with Patrick Industries, under which LCI will become a wholly owned subsidiary of Patrick via a two-step merger structure. No financial terms of the Monomoy proposal were disclosed.
- · Merger Agreement with Patrick Industries entered into on June 30, 2026
- · Monomoy Capital Partners' unsolicited non-binding proposal announced October 28, 2026
- · Board determination on Monomoy Proposal made October 30, 2026
- · Patrick's Form S-4 registration statement (File No. 333-299100) declared effective by SEC on October 19, 2026
- · Definitive joint proxy statement/prospectus mailed to stockholders on or about October 19, 2026
- · Merger structure: First Merger Sub merges into LCI (LCI survives as Patrick subsidiary), followed immediately by Second Merger of LCI into Second Merger Sub (Second Merger Sub survives as Patrick subsidiary)
- · LCI 10-K for fiscal year ended December 31, 2025 filed February 26, 2026; Patrick 10-K filed February 19, 2026
30-10-2026
Naploy Corp. filed its 10-K for fiscal year ended July 31, 2026, reporting revenue more than doubled to $18,097 (from $7,950, +127.6% YoY). However, total operating expenses surged 73.6% to $49,773 (from $28,664), driven largely by General and Administrative Expenses jumping to $21,064 from just $88, pushing net loss wider to $31,676 from $20,714 (+52.9% YoY). The company remains deeply loss-making with negative stockholders' equity of $42,804 and an accumulated deficit of $79,071, funded primarily by $21,162 in related-party financing.
- · Net loss per share (basic and diluted) was $(0.01) in both FY2026 and FY2025
- · General and administrative expenses exploded to $21,064 from $88, a roughly 238x increase
- · No income tax provision recorded in either year; tax benefit fully offset by valuation allowance
- · Deferred revenue rose to $19,354 from $10,450, suggesting higher advance billings
- · Intangible assets, net declined to $17,625 from $26,625 due to $9,000 annual amortization
- · Total current liabilities ($100,657) far exceed total current assets ($40,228), indicating a working capital deficit
- · Company funded operations largely through related-party advances ($21,162 in FY2026 vs $162 in FY2025)
- · No cash paid for interest or taxes in either period
- · Shares outstanding flat at 3,803,370 in FY2026 (68,750 shares issued for $1,375 cash in FY2025)
30-10-2026
CubeSmart reported Q3 2026 net income attributable to common shareholders of $94.4 million, up from $82.9 million in Q3 2025, with diluted EPS rising to $0.42 from $0.36. FFO, as adjusted, was $150.3 million versus $149.0 million, and FFO per diluted share grew 1.5% to $0.66, while same-store NOI rose 2.1% on a 1.9% revenue increase and 1.3% expense increase. However, growth was modest and interest expense climbed $1.7 million to $31.1 million as average debt rose to $3.55 billion and the weighted average effective interest rate ticked up to 3.37% from 3.32%.
- · 2026 guidance: diluted EPS of $1.60 to $1.62 and fully diluted FFO per share, as adjusted, of $2.58 to $2.60
- · Quarterly dividend of $0.53 per common share declared July 28, 2026, paid October 15, 2026 to holders of record October 1, 2026
- · 15 stores to be contributed to Heitman JV span Connecticut (3), Georgia (1), North Carolina (2), Ohio (1), Texas (2), Utah (4) and Virginia (2), totaling approximately 0.9 million square feet; CubeSmart to retain 20% interest, Heitman 80%
- · JV transaction scheduled to close in Q4 2026
- · New $300 million unsecured term loan matures January 10, 2031, priced at SOFR + 0.80% at current credit rating and leverage; proceeds repaid revolver borrowings
- · One JV development property under construction in New York expected to open in Q3 2027
- · Conference call scheduled 11:00 a.m. ET on Friday, October 30, 2026
30-10-2026
Eos SENOLYTIX reported interim aged-rat data for its MitoXcel geropeptide PTC-2105, showing preserved Rotarod motor performance at Week 16 (78.4 percentage-point difference vs vehicle, p=0.012) and a 14.5% fat-mass reduction at Week 8 with the 12.5 mg/kg dose (vs 8.2% for vehicle, p=0.018). However, the data are preliminary from very small groups (n=3-4 for Rotarod, n=7-8 for fat mass), and the grip-strength improvement (+30.7% vs +7.3%) was not statistically significant (p=0.396). The filing also confirms Pulmatrix stockholders approved the previously announced merger at an October 26, 2026 special meeting, with the deal anticipated to close in Q4 2026 under the new ticker "MTXL."
- · Study conducted at Einstein's BIO-VITAL facility: 32-week aged-rat study, staggered enrollment, two once-weekly SC doses (0.5 and 12.5 mg/kg) vs vehicle, assessments every eight weeks across five time points
- · 16-week functional data available only for the oldest cohort (n=39 rats enrolled); Rotarod analysis based on n=3 (treated) and n=4 (vehicle)
- · PTC-2105 has been well tolerated with no adverse safety signals observed to date; non-GLP dose-range-finding toxicology studies in rats and dogs have begun
- · First-in-human trials targeted for 2027, subject to IND clearance; Phase 1b randomized, double-blind, placebo-controlled study in participants aged 60+ with sarcopenia planned to begin 2027
- · Pulmatrix special meeting held October 26, 2026 approved all proposals including the Merger; Form S-4 (File No. 333-297342) declared effective September 25, 2026
- · Combined company expected to trade on Nasdaq under ticker "MTXL"; merger anticipated to close in Q4 2026 subject to customary closing conditions
- · Data presented at 2026 ICFSR (March 10-12, 2026, Washington, DC) and World Mitochondria Society "Targeting Mitochondria" meeting (October 22-24, 2026, Berlin)
- · Speedy the mouse at 168 weeks has lived more than 7.2 months past the last untreated control (died at 137 weeks) and past the ~155-week literature lifespan ceiling
- · PTC-2105 is exclusively licensed for FDA-regulated therapeutic uses outside cancer, with initial focus on sarcopenia and sarcopenic obesity
30-10-2026
Pharmaceutical Resource Technology filed a 10-Q/A with restated comparative financials showing a sharp deterioration: 6-month revenue rose 3.7% YoY to $5,635,715 but gross profit fell 19.1% to $2,508,725 as cost of revenue jumped 34.2%, driving a net loss of $322,177 versus a $880,244 profit a year earlier. The 3-month period was also weaker, with revenue down 4.2% to $2,902,598 and net income down 71.0% to $273,699, though operating cash flow of $1,090,585 and a $726,385 cash increase kept liquidity positive.
- · Gross margin compressed to 44.5% in 6M 2026 from 57.1% in 6M 2025
- · Intangible assets carrying amount fell to $18,599,444 at June 30, 2026 from $19,854,017 a year earlier
- · Property, plant and equipment carrying amount declined to $5,258,554 from $6,860,849
- · Accumulated deficit of $335,260 at June 30, 2026 versus accumulated profit of $602,341 at June 30, 2025
- · No common stock was issued in 6M 2026 versus $1,003,673 raised in 6M 2025
- · No debt repayment activity in 6M 2026 versus $2,500,000 repaid to Directors in 6M 2025
- · All revenue, cost of revenue and G&A are related-party transactions with Superbee; total related-party transactions $15,015,579
- · Amortization of $807,286 and depreciation of $684,006 plus $78,197 right-of-use depreciation in 6M 2026
- · Income tax expense was zero in both periods
30-10-2026
Ryan Specialty reported Q3 2026 total revenue of $789.963M, up 4.7% YoY from $754.577M, while nine-month revenue rose 8.8% to $2,501.839M. Q3 operating income grew 27.1% to $140.828M and net income attributable to the company rose 18.0% to $36.681M, but fiduciary investment income declined 0.9% YoY and nine-month operating cash flow fell 19.3% to $306.933M. The company repurchased $450.253M of Class A stock in the nine months, reducing shares outstanding and total equity to $901.748M from $1,254.051M at year-end 2025.
- · Nine-month net income attributable to Ryan Specialty rose 74.4% to $96.642M from $55.419M
- · Nine-month diluted EPS increased to $0.74 from $0.41
- · Change in contingent consideration swung to a $34.187M expense in 9M 2026 from a $2.833M benefit in 9M 2025
- · Q3 2026 change in contingent consideration was a $10.658M benefit versus an $11.968M expense in Q3 2025
- · Income tax expense rose to $36.998M in 9M 2026 from $65.659M in 9M 2025
- · Goodwill was $3,216.252M and customer relationships $1,314.994M at September 30, 2026
- · Fiduciary cash and receivables were $4,935.368M at September 30, 2026
- · Nine-month 2026 capital expenditures were $52.233M versus $50.678M prior year
- · Nine-month 2025 investing outflows included $636.925M for business combinations; none in 2026
- · Company recorded an $11.704M impairment of internally-developed software in 9M 2026
- · Class A shares outstanding fell to 120,364,827 from 129,603,426 at December 31, 2025 due to buybacks
30-10-2026
Dominion Energy reported Q3 2026 GAAP net income of $1.2 billion ($1.30/share) versus $1.0 billion ($1.16/share) in Q3 2025, with operating earnings (non-GAAP) of $1.1 billion ($1.28/share) up from $921 million ($1.06/share). Operating revenue rose 24% YoY to $5,617 million, driven by Dominion Energy Virginia (+$183M operating earnings) and South Carolina (+$62M), while Contracted Energy declined $31M and Corporate and Other remained a $87M loss. However, nine-month GAAP net income fell to $2,121 million from $2,431 million (-13% YoY) and diluted EPS declined to $2.37 from $2.81, reflecting $661M of pre-tax losses in the nine-month period. The company expects to land in the top half of its 2026 operating EPS guidance range of $3.45-$3.69 and reaffirmed credit, dividend, and long-term growth guidance; the release also references a proposed merger with NextEra Energy.
- · Nine-month 2026 GAAP net income fell to $2,121M from $2,431M (-12.7% YoY) and diluted EPS fell to $2.37 from $2.81 (-15.7%)
- · Contracted Energy segment operating earnings declined to $134M from $165M (-18.8% YoY) in Q3
- · Corporate and Other segment posted a $87M operating loss in Q3 2026 (improved from $91M loss) and a $249M nine-month loss vs $166M prior year
- · Nine-month 2026 pre-tax loss adjustment to reported earnings was $661M vs $146M income in prior year
- · Q3 2026 total operating expenses rose to $3,775M from $3,188M (+18.4% YoY)
- · Interest and related charges increased to $623M from $527M (+18.2% YoY)
- · 2026 operating EPS guidance range reaffirmed at $3.45 to $3.69 per share; company expects top half of range
- · Average diluted shares rose to 882.1M from 855.4M
- · Series C preferred stock dividends of $11M impacted EPS calculations
- · Q3 2026 operating revenue growth driven by higher electric fuel and energy-related purchases ($1,603M vs $1,337M)
30-10-2026
3EDGE Asset Management, LP filed its Q3 2026 13F-HR disclosing a 95-line ETF-heavy portfolio as of September 30, 2026. The largest positions are concentrated in short-duration Treasuries and gold: SPDR Bloomberg 1-3 Month T-Bill ETF at $391.4M, World Gold Trust (SPDR Gold MiniShares) at $115.6M, iShares 0-3 Month Treasury at $112.9M, and SPDR S&P 500 ETF at $117.1M. The book is dominated by fixed-income/cash-like and gold exposures, with smaller allocations to sector SPDRs, international equity ETFs, and crypto vehicles (Bitwise Bitcoin ETF $1.5M, Grayscale Bitcoin Mini $0.3M).
- · Portfolio is heavily weighted toward cash-like/short-duration Treasuries and gold, with the top four positions (SPDR 1-3 Month T-Bill $391.4M, WisdomTree Floating Rate Treasury $229.4M, Franklin FTSE Japan $203.8M, iShares Core S&P 500 $119.2M) representing a large share of reported value.
- · Crypto exposure is minimal: Bitwise Bitcoin ETF $1.5M, Fidelity Wise Origin Bitcoin $0.3M, Grayscale Bitcoin Mini $0.3M, Grayscale CoinDesk Crypto $0.2M.
- · The firm holds its own ETFs: 3EDGE Hard Asset ETF $2.5M, 3EDGE International ETF $3.5M, 3EDGE Fixed Income ETF $4.7M, 3EDGE Dynamic US ETF $4.1M.
- · All positions are reported as sole voting authority with no shared or no-voting shares disclosed.
- · Filing signed by Kristi M. Hillyer (listed as Kristi McDermott, COO & CCO) on October 30, 2026, for period ended September 30, 2026.
30-10-2026
Arbejdsmarkedets Tillaegspension (ATP), the Danish pension fund, filed its Q3 2026 13F-HR disclosing 164 US equity positions valued at approximately $3.93 billion as of September 30, 2026. The portfolio is broadly diversified across large-cap US equities, with the largest disclosed holdings including Lam Research ($30.45M), KLA Corp ($29.14M), Micron ($28.84M), Amgen ($28.19M) and NetApp ($27.79M), while smaller positions include Armstrong World ($5.52M), New York Times ($5.19M) and Ross Stores ($13.12M). The filing is a routine quarterly holdings disclosure with no period-over-period comparison data provided, so no change metrics can be calculated.
- · Filing is for period 09-30-2026, filed 10-30-2026 under SEC File Number 028-26080
- · All 164 positions are held SOLE with no shared or discretionary voting authority reported
- · Portfolio is heavily weighted toward mid/large-cap industrials, financials, utilities and REITs rather than mega-cap tech concentration
- · Largest single position (Lam Research, $30.45M) represents under 1% of total portfolio, indicating high diversification
- · Smallest positions include New York Times ($5.19M) and Armstrong World Industries ($5.52M)
- · No period-over-period holdings change data is included in this filing, so quarter-over-quarter position changes cannot be computed
30-10-2026
Barnes Dennig Private Wealth Management LLC filed its Q3 2026 13F-HR disclosing 363 holdings valued at $118,681,334 as of September 30, 2026. The portfolio is heavily concentrated in mega-cap technology and blue-chip equities, led by Applied Materials ($8.29M), Bank of New York Mellon ($5.58M), Apple ($5.49M), Marvell Technology ($5.48M) and Alphabet Class A ($5.19M), alongside a broad mix of index ETFs. No prior-period holdings data was included in this filing, so period-over-period position changes cannot be calculated.
- · Filing is a 13F-Holdings Report for the period ending 09-30-2026, filed 10-30-2026 under SEC File No. 028-25512
- · All 363 positions are held in sole voting/discretionary authority (0 shared, 0 none)
- · Portfolio is diversified across individual equities and a large complement of index/ETFs, with top holdings each representing roughly 2-7% of total value
- · Notable smaller positions include NVIDIA ($847,061), Eli Lilly ($779,872), Meta Platforms ($23,206) and Reddit ($23,218)
- · Filer is an Ohio-based (Cincinnati) registered investment adviser; no prior-quarter comparison data was provided in this filing
30-10-2026
Capital Investment Advisory Services, LLC filed its Q3 2026 13F-HR disclosing a 1,336-line institutional holdings portfolio as of September 30, 2026. The largest positions are concentrated in mega-cap technology: Apple ($43.2M), Alphabet Class C ($29.9M), Amazon ($29.3M), Broadcom ($16.5M), and AMD ($10.0M), alongside sizable ETF allocations including iShares US Equity ($14.9M) and iShares AAA CLO ($10.7M). The filing is a routine quarterly holdings disclosure with no period-over-period comparison data provided, so no growth or decline metrics can be calculated.
- · Filing is for the period ended September 30, 2026, filed October 30, 2026 under SEC File No. 028-17635 (CIK 0001659203).
- · Filer is a North Carolina-based investment adviser (Raleigh, NC) with fiscal year end December 31.
- · All reported positions are held in sole voting authority with zero shared or discretionary-other voting authority.
- · Portfolio includes fixed-income and convertible notes such as Akamai 0.375% 9/0 notes ($54,437), Amphastar 2.000% 3/1 notes ($14,957), and BioMarin 1.250% 5/1 notes ($41,929).
- · Significant ETF/closed-end fund exposure includes BlackRock Enhanced Equity Dividend ($1.39M), BlackRock Enhanced Large Cap ($2.10M), and BlackRock Multi-Sector Income Trust ($1.69M).
- · No period-over-period comparison data is disclosed in this 13F-HR, so no quarter-over-quarter position changes can be calculated.
30-10-2026
Opus Capital Group, LLC filed its Q3 2026 13F-HR disclosing 147 positions valued at approximately $1.02 billion as of September 30, 2026. The portfolio is heavily ETF-driven, with the largest holdings being Vanguard S&P 500 ETF ($178.1M), iShares Core MSCI EAFE ETF ($75.7M), Vanguard Intermediate-Term Treasury Index ($54.3M), iShares Core S&P Small-Cap ETF ($48.6M), and Avantis US Large Cap Value ETF ($45.0M). The filing shows a barbell of broad index ETFs alongside a handful of concentrated single-stock bets, including several near-zero-value legacy or speculative positions (e.g., Applied Visual Sciences at $0 on 2,000,000 shares, Metaverse Capital and Marathon Group at $0).
- · Portfolio is dominated by ETFs; the top holding Vanguard S&P 500 ETF ($178.1M) alone represents roughly 17% of total reported value
- · Largest single-stock position is Procter & Gamble at $15.8M (109,037 shares), followed by Apple at $5.6M and Nvidia at $2.5M
- · Three positions are carried at $0 reported value despite large share counts: Applied Visual Sciences (2,000,000 shares), Metaverse Capital Corp (50,000 shares), and Marathon Group Corp (300,000 shares)
- · Sellas Life Sciences is a notable speculative position at $4.97M (403,635 shares)
- · Fixed income and Treasury ETF exposure is substantial, including Vanguard Intermediate-Term Treasury ($54.3M), Vanguard Short-Term Treasury ($34.4M), Dimensional Core Fixed Income ($34.3M), and iShares 0-5 Year TIPS ($30.4M)
- · Municipal bond ETFs total roughly $21.7M across iShares Short-Term National Muni, iShares National AMT-Free Muni, Vanguard Short Duration Tax-Exempt, and Vanguard Core Tax-Exempt
- · Filer was formerly named Opus Capital Management, Inc. (name change 12/19/2005); SEC file number 028-11411, CRD 801-51533
- · All positions are held solely (SOLE voting authority) with no shared or discretionary-other breakdown reported
30-10-2026
Mastech Digital reported Q3 2026 revenue of $41.987M, down 13.4% YoY from $48.496M, with net income collapsing to just $7K from $941K as operating income fell to $13K from $820K. Both segments declined: Data & AI revenue fell 6.8% YoY to $14.122M and Talent revenue dropped 16.4% to $27.865M. Nine-month results improved to net income of $171K versus a $363K loss, helped by lower SG&A ($35.334M vs $41.179M), but operating income remained negative at -$261K and operating cash flow fell sharply to $1.718M from $6.759M.
- · Q3 2026 basic and diluted EPS were $0.00 versus $0.08 in Q3 2025
- · Nine-month 2026 diluted EPS was $0.01 versus $(0.03) in 2025
- · Data & AI fixed-price contracts grew to $1.423M in Q3 2026 from $195K in Q3 2025
- · US revenue fell to $40.791M in Q3 2026 from $48.078M, while India and Other rose to $799K from $306K
- · Income tax expense of $243K on $250K pre-tax income in Q3 2026 (effective rate ~97%)
- · Accrued payroll and related costs fell to $11.459M from $15.391M at year-end 2025
- · Intangible assets declined to $5.945M from $7.755M at December 31, 2025 due to amortization
- · No treasury stock repurchases in 9M 2026 versus $1.592M in 9M 2025
- · Foreign currency translation losses of $825K in 9M 2026 drove total comprehensive loss of $654K
30-10-2026
Lyell Wealth Management, LP filed its Q3 2026 13F-HR disclosing 233 holdings valued at approximately $1.69B as of September 30, 2026. The portfolio is heavily concentrated in mega-cap technology, with NVIDIA ($132.3M), Alphabet Class C ($94.3M) and Class A ($66.5M), Palo Alto Networks ($67.4M), Apple ($61.9M), Microsoft ($48.1M), Amazon ($45.1M), AMD ($41.8M) and Meta ($41.4M) as the largest positions. The book also shows meaningful fixed-income laddering via iShares iBonds ETFs and broad index/sector ETF exposure, indicating a diversified core-plus-satellite structure; no prior-period holdings were included, so period-over-period changes cannot be calculated.
- · Total reported portfolio value: $1,687,179,645 across 233 positions as of September 30, 2026
- · All positions are held sole (no shared or other-manager discretion reported)
- · Fixed-income iBonds ladder totals roughly $70M+ across Dec 2026-Dec 2035 maturities, with the Dec 2027 tranche ($16.8M) the largest
- · Top 10 positions (NVIDIA, Alphabet A/C, Palo Alto, Apple, Microsoft, Amazon, AMD, Meta, ASML) account for roughly $600M, indicating high mega-cap tech concentration
- · Small satellite positions include Sana Biotechnology ($30,608), Grab Holdings ($120,668) and Atlas Energy Solutions ($177,340)
- · Filing signed by Kevin Connell, Chief Compliance Officer, dated October 30, 2026; SEC file number 028-17772
- · No prior-quarter 13F data included, so quarter-over-quarter position changes cannot be determined from this filing
30-10-2026
First Trust Portfolios L.P., First Trust Advisors L.P., and The Charger Corporation filed a joint Schedule 13G/A disclosing beneficial ownership of 170,701 shares (4.81%) of First Trust Exchange-Traded Fund VIII (FT Vest Nasdaq-100 Moderate Buffer ETF - August) as of September 30, 2026. The filing is routine in nature, with all three reporting persons disclaiming beneficial ownership and stating the shares were acquired in the ordinary course of business without intent to influence control. No voting power is held by the reporting persons, as shares held in sponsored unit investment trusts are voted by the trustee.
- · Filing is a Schedule 13G/A under Rule 13d-1(b), indicating a qualified institutional investor exemption
- · Each reporting person reports 0 sole voting power and 0 sole dispositive power, with 170,701 shared dispositive shares
- · No individual unit investment trust sponsored by First Trust Portfolios L.P. holds more than 3% of any registered investment company issuer's shares
- · The Charger Corporation serves as General Partner of both First Trust Portfolios L.P. and First Trust Advisors L.P.
- · CUSIP of the subject security: 33740F193
- · Reporting persons are organized in Illinois (IL)
30-10-2026
Virtus Family Office LLC filed its Q3 2026 13F-HR disclosing 62 equity positions valued at $130,881,165 as of September 30, 2026, with all shares held in sole voting authority. The portfolio is heavily ETF-weighted, with the largest holdings being Invesco RAFI Emerging Markets ETF ($8,383,468), Shinhan Financial Group ADR ($6,902,981), Taiwan Semiconductor ADR ($6,744,147), and Vanguard Short-Term Corporate Bond ETF ($6,501,206). Concentration is notable, with the top five positions representing roughly 26% of total reported value, while several small positions such as ProKidney ($45,650) and Salesforce ($203,250) remain marginal allocations.
- · All 62 positions are held with sole voting authority; no shared or no-vote shares reported
- · Portfolio is ETF-heavy, with ETFs comprising a substantial share of the 62 reported line items
- · International exposure spans Brazil (Ambev), China (PDD, ZTO, Qfin), Taiwan (TSMC), South Korea (Shinhan), Ireland (Ryanair), Israel (InMode), and the Netherlands (iShares MSCI Netherlands ETF)
- · Smallest positions include ProKidney at $45,650 and Salesforce at $203,250, indicating minimal allocations
- · Filing signed by Norma Angelica Peralta Morales, Chief Compliance Officer, dated 10-30-2026
- · Filer is a Texas-based LLC (EIN 831282274) with SEC file number 028-22698
30-10-2026
Joseph P. Lucia & Associates, LLC filed its Q3 2026 13F-HR disclosing 194 positions with an aggregate reported value of approximately $345.5 million as of September 30, 2026. The portfolio is heavily ETF-centric, with the largest holdings being VanEck Semiconductor ETF ($21.6M), Apple ($15.5M), NVIDIA ($13.2M), and Schwab US Broad Market ETF ($10.7M), alongside sizable sector-equal-weight and covered-call income ETF positions. The book is diversified across mega-cap tech, broad-market and factor ETFs, and defensive/dividend vehicles, with no single position exceeding roughly 6% of reported value.
- · Filing is a 13F-HR for the period ended 09-30-2026, filed 10-30-2026 (SEC File No. 028-19484, CIK 0001775391).
- · Portfolio is dominated by ETFs rather than individual equities; the top individual stock holdings are Apple ($15.5M), NVIDIA ($13.2M), Amazon ($9.3M), Meta ($3.3M), and Alphabet Class A ($2.3M).
- · Notable crypto exposure via Grayscale Bitcoin Trust ($1.1M), Grayscale Bitcoin Mini Trust ($0.9M), and iShares Bitcoin Trust ($0.6M).
- · Small speculative/emerging positions include SpaceX Class A ($0.5M), CoreWeave ($0.3M), Archer Aviation ($54K), and Farmmi ($32K).
- · No period-over-period comparison data is included in this filing (13F-HR reports a single quarter's holdings without prior-period deltas).
- · Filer is a New York-based advisory firm (Yorktown Heights, NY) with 194 reported positions.
30-10-2026
Sky Constant Century Inc. appointed Mr. Jin Xiong to its Board of Directors effective October 30, 2026, citing his 20+ years of management experience in consumer products, personal care, cosmetics and retail. Concurrently, the Company disclosed it is evaluating potential strategic cooperation with Jipinlong International Cosmetics Limited, a Hong Kong company chaired by Mr. Xiong, which could extend to a future business combination, acquisition or asset integration. However, the Company emphasized discussions remain preliminary, no definitive agreement has been executed, and there is no assurance any transaction will be completed; any deal would be subject to conflict-of-interest review given Xiong's dual roles.
- · Mr. Xiong holds a Bachelor of Laws and a Master's degree in Management from Wuhan University and an MBA from China University of Geosciences
- · Jipinlong is focused on overseas retail, consumer products and supply-chain business development, with particular emphasis on the United States and Vietnam
- · Potential areas of cooperation include consumer retail operations, brand development, supply-chain coordination, cross-border commerce and international market expansion
- · No definitive agreement relating to any acquisition, business combination or asset integration has been executed as of the report date
- · The Company is an Emerging Growth Company and its securities are not registered on any exchange (Trading Symbol: N/A)
- · Company principal offices are located in Tsim Sha Tsui, Hong Kong
30-10-2026
Drystone LLC filed its Q3 2026 13F-HR disclosing 18 positions with an aggregate reported value of $118,939,538 as of September 30, 2026. The portfolio is concentrated in large-cap equities and ETFs, led by Vanguard Total International Stock ETF at $20,844,279 and Trane at $14,575,451, while Apple ($32,636) and Fastenal ($495,300) are the smallest holdings. The filing reflects a buy-and-hold institutional book with no options or shared/other voting authority disclosed across any position.
- · All 18 positions are held with sole voting authority; zero shares reported under shared or other voting authority
- · Portfolio spans 15 individual common stocks and 3 Vanguard ETFs
- · Other holdings not detailed above include Kenvue ($4,281,901 / 242,463 shares), Pfizer ($4,731,901 / 165,915 shares), Mettler-Toledo ($4,682,434 / 3,099 shares), Ritchie Global Class A ($2,685,870 / 33,000 shares), and Adobe ($2,500,175 / 10,420 shares)
- · Filer is a Virginia-based LLC (CIK 0001910462, SEC File 028-21838); report signed by Christopher H. Jackson on 10-27-2026
- · No period-over-period comparison is possible as only a single-quarter snapshot is provided in this filing
30-10-2026
Vanguard Capital Management LLC filed a Schedule 13G/A disclosing beneficial ownership of 2,255,384 shares of Ashland Inc. common stock, representing 4.92% of the class as of September 30, 2026. The filing reports sole dispositive power over all 2,255,384 shares and sole voting power over 355,092 shares, with no shared voting or dispositive power. The position sits just below the 5% threshold, and Vanguard certified the securities were acquired in the ordinary course of business and not for the purpose of influencing control.
- · Filing is a Schedule 13G/A under Rule 13d-1(b), indicating a qualified institutional investor status
- · Vanguard reports 0 shared voting power and 0 shared dispositive power
- · Ownership stake of 4.92% remains below the 5% reporting threshold that would trigger additional disclosure obligations
- · No single other person's interest in the reported securities exceeds 5%
- · Ashland Inc. is classified under SIC 5160 (Wholesale-Chemicals & Allied Products) and incorporated in Delaware
- · Vanguard's business address is 100 Vanguard Blvd, Malvern, PA 19355; Ashland's is 8145 Blazer Drive, Wilmington, DE 19808
30-10-2026
Franklin Templeton ETF Trust filed a DEFA14A definitive additional proxy solicitation for the Franklin Intelligent Machines ETF (IQM), announcing that the special shareholder meeting originally convened on October 30, 2026 has been adjourned to December 4, 2026 to secure additional votes. The Board of Trustees unanimously recommends voting 'FOR' a proposal to amend the fund's fundamental investment policy regarding industry concentration, and management notes that more than 98% of shares voted so far are in favor. The filing is a routine solicitation update with no financial or performance data disclosed.
- · Special shareholder meeting originally scheduled and convened October 30, 2026, adjourned to December 4, 2026
- · Proxy statement was mailed in September 2026; additional information at https://proxyvotinginfo.com/p/IQM2026
- · Proxy agent Sodali Fund Solutions (SFS) contact: (800) 741-9946, specialists available Monday-Friday 10 a.m. to 11 p.m. ET
- · Four voting methods offered: online, phone, mobile QR code, and mail via prepaid envelope
- · No filing fee required for this solicitation
- · SEC File Number 811-23124; CIK 0001655589; incorporated in Florida; fiscal year end March 31
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: US SEC Filings Daily Market Digest
🇺🇸 More from United States
View all →October 23, 2026
US Pre-Market SEC Filings Roundup — October 23, 2026
US Pre-Market SEC Filings Roundup
October 23, 2026
US Merger & Acquisition SEC Filings — October 23, 2026
US Merger & Acquisition SEC Filings
October 23, 2026
USA Insider Trading Pulse — October 23, 2026
USA Insider Trading Pulse
October 23, 2026
US Corporate Board Director Changes SEC Filings — October 23, 2026
US Corporate Board Director Changes SEC Filings